D.A. Wallach is an early-stage investor who primarily backs biotechnology, life sciences, and healthcare companies. See sector focus and contact routes.
D.A. Wallach is an early-stage investor who primarily backs biotechnology, life sciences, and healthcare companies, with check sizes typically ranging from $2 million to $6 million across seed through Series B rounds[8]. His notable portfolio includes industry-defining technology and health startups such as Spotify, SpaceX, Ripple, Neuralink, Doctor on Demand, and Beam[1][8]. Wallach’s distinctive thesis focuses on reinventing medicine by investing in highly technical companies with significant intellectual property, often originating from academia, to address major global health challenges[1][8].
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Los Angeles.
Investors like D.A. Wallach · Full investor directory · Investor access · Company funding database